Medicare Price ‘Negotiation’ Would Have Stymied Verzenio Advance In Early Cancer – Lilly’s Ricks

 
• By Cathy Kelly

‘It takes longer than nine years’ to profit from small molecule drug R&D, company CEO maintains in arguments against the negotiation process, and its timelines, in the Senate drug pricing reform legislation.

Lilly Gets Specific About The Innovation Argument Against Price Negotiation • Source: Shutterstock

More from Pricing Debate

More from Market Access